Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein

• aspirin (75 mg or 150 mg) or • LMWH. [2018] 1.6.3 Consider pharmacological VTE prophylaxis with LMWH for people with pancreatic cancer who are receiving chemotherapy. [2018] 1.6.4 If giving VTE prophylaxis to people with cancer (see recommendations 1.6.2 and 1.6.3), continue for as long as they are receiving chemotherapy. [2018] 1.7 Interventions for people having palliative care 1.7.1 Consider pharmacological VTE prophylaxis for people who are having palliative care. Take into account temporary increases in thrombotic risk factors, risk of bleeding, likely life expectancy and the views of the person and their family members or carers (as appropriate): • Use LMWH as first-line treatment. • If LMWH is contraindicated, use fondaparinux sodium. [2018] In March 2018, the use of LMWH and fondaparinux sodium in young people under 18 was off label. See NICE's information on prescribing medicines. 1.7.2 Do not offer VTE prophylaxis to people in the last days of life. [2018] 1.7.3 For recommendations on shared decision-making in the last days of life, see the NICE guideline on care of dying adults in the last days of life. [2018] 1.7.4 Review VTE prophylaxis daily for people who are having palliative care, taking into account the views of
